IRIS Accounts Production v23.3.0.418 12963921 director 1.4.22 31.3.23 31.3.23 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh129639212022-03-31129639212023-03-31129639212022-04-012023-03-31129639212020-10-20129639212020-10-212022-03-31129639212022-03-3112963921ns10:Originalns15:EnglandWales2022-04-012023-03-3112963921ns14:PoundSterlingns10:Original2022-04-012023-03-3112963921ns10:Originalns10:Director12022-04-012023-03-3112963921ns10:Original2022-04-012023-03-3112963921ns10:Original2023-03-3112963921ns10:Originalns10:PrivateLimitedCompanyLtd2022-04-012023-03-3112963921ns10:Originalns10:SmallEntities2022-04-012023-03-3112963921ns10:Originalns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3112963921ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3112963921ns10:SmallCompaniesRegimeForAccountsns10:Original2022-04-012023-03-3112963921ns10:Originalns10:FullAccounts2022-04-012023-03-3112963921ns10:Originalns10:OrdinaryShareClass12022-04-012023-03-3112963921ns10:Originalns10:RegisteredOffice2022-04-012023-03-3112963921ns10:Original2022-03-3112963921ns10:Originalns5:CurrentFinancialInstruments2023-03-3112963921ns10:Originalns5:CurrentFinancialInstruments2022-03-3112963921ns5:ShareCapitalns10:Original2023-03-3112963921ns5:ShareCapitalns10:Original2022-03-3112963921ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-03-3112963921ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-03-3112963921ns10:Originalns5:ComputerEquipment2022-04-012023-03-3112963921ns10:Original2020-10-212022-03-3112963921ns10:Originalns5:ComputerEquipment2022-03-3112963921ns10:Originalns5:ComputerEquipment2023-03-3112963921ns10:Originalns5:ComputerEquipment2022-03-3112963921ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3112963921ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-03-3112963921ns10:Originalns10:OrdinaryShareClass12023-03-31
REGISTERED NUMBER: 12963921 (England and Wales)







Unaudited Financial Statements

for the Year Ended 31 March 2023

for

Think Gene Ltd

Think Gene Ltd (Registered number: 12963921)






Contents of the Financial Statements
for the Year Ended 31 March 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Think Gene Ltd

Company Information
for the Year Ended 31 March 2023







DIRECTOR: Mr K J P Gould





REGISTERED OFFICE: 18 Hollyhock Way
Biggleswade
Bedfordshire
SG18 8YQ





REGISTERED NUMBER: 12963921 (England and Wales)





ACCOUNTANTS: Haines Watts
Military House
24 Castle Street
Chester
Cheshire
CH1 2DS

Think Gene Ltd (Registered number: 12963921)

Balance Sheet
31 March 2023

31.3.23 31.3.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,783 3,565

CURRENT ASSETS
Debtors 5 661 -
Cash at bank 33,726 52,137
34,387 52,137
CREDITORS
Amounts falling due within one year 6 2,064 12,997
NET CURRENT ASSETS 32,323 39,140
TOTAL ASSETS LESS CURRENT
LIABILITIES

34,106

42,705

PROVISIONS FOR LIABILITIES 339 677
NET ASSETS 33,767 42,028

CAPITAL AND RESERVES
Called up share capital 7 2 2
Retained earnings 33,765 42,026
SHAREHOLDERS' FUNDS 33,767 42,028

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Think Gene Ltd (Registered number: 12963921)

Balance Sheet - continued
31 March 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 1 November 2023 and were signed by:





Mr K J P Gould - Director


Think Gene Ltd (Registered number: 12963921)

Notes to the Financial Statements
for the Year Ended 31 March 2023

1. STATUTORY INFORMATION

Think Gene Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements are presented in sterling, which is the functional currency of the company, rounded to the nearest £1.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding rebates, discounts, value added tax and other sales taxes. Turnover from the rendering of services is recognised by the stage of completion of the contract.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

Think Gene Ltd (Registered number: 12963921)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 April 2022
and 31 March 2023 5,348
DEPRECIATION
At 1 April 2022 1,783
Charge for year 1,782
At 31 March 2023 3,565
NET BOOK VALUE
At 31 March 2023 1,783
At 31 March 2022 3,565

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Other debtors 661 -

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Taxation and social security - 10,681
Other creditors 2,064 2,316
2,064 12,997

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.23 31.3.22
value: £    £   
2 Ordinary £1 2 2